Phase 2 Metastatic Prostate Cancer trials recruiting now

All Metastatic Prostate Cancer trials, every phase

Other phases for Metastatic Prostate Cancer

Phase 2 Metastatic Prostate Cancer trials

• A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
  NCT07567846 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 5 locations
• A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
  NCT06782555 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of Tarlatamab for People With Prostate Cancer
  NCT07111507 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 10 locations
• ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium
  NCT07414940 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
  NCT06738303 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Combination of TURP and Standard Systemic Therapy for MPCa
  NCT06655259 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT)
  NCT05404139 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: Male · 2 locations
• First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
  NCT07529717 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: Male · 8 locations
• High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
  NCT05011383 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 17 locations
• Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
  NCT07590934 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: Male · 37 locations
• Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer
  NCT06854250 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 1 location
• Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
  NCT07181161 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 130 Years · Sex: Male · 52 locations
• Study of AZD0754 in Participants With Metastatic Prostate Cancer
  NCT06267729 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 130 Years · Sex: Male · 15 locations
• Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
  NCT06800313 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 18 locations
• Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
  NCT06582628 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 12 locations
• Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
  NCT06616597 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
  NCT04787744 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: Male · 20 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.